Figure 11.

In vivo study reveals the noncytotoxicity of formulated nanomaterials in vital organs and their efficacy in minimizing tumor growth. (A) Tumor volume. (B) Body weight of mice treated with saline, TPT, MT, TPT+ MT, TPT-MSN-TAT, TPT-MSN-TAT-CAH-MT, and PMS nanocomposites after 24 days. (C) Hematoxylin and eosin staining of breast cancer induced mice tissue section collected from different groups of mice after 24 days of treatment and (D) the PMS uptake by different intracellular organs of dissected mice. p ≤ 0.05 value assumes statistically significant.